Cannabidiol inhibits sucrose self-administration by CB1 and CB2 receptor mechanisms in rodents
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cannabidiol inhibits sucrose self-administration by CB1 and CB2 receptor mechanisms in rodents
Authors
Keywords
-
Journal
ADDICTION BIOLOGY
Volume -, Issue -, Pages e12783
Publisher
Wiley
Online
2019-06-19
DOI
10.1111/adb.12783
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Progress in Brain Cannabinoid CB2 Receptor Research: From Genes to Behavior
- (2019) Chloe J. Jordan et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Cannabinoid CB 1 and CB 2 receptor mechanisms underlie cannabis reward and aversion in rats
- (2019) Krista J. Spiller et al. BRITISH JOURNAL OF PHARMACOLOGY
- GPR3, GPR6, and GPR12 as novel molecular targets: their biological functions and interaction with cannabidiol
- (2018) Alyssa S. Laun et al. ACTA PHARMACOLOGICA SINICA
- Cannabidiol does not display drug abuse potential in mice behavior
- (2018) Adrián Viudez-Martínez et al. ACTA PHARMACOLOGICA SINICA
- Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors
- (2018) Mylyne Tham et al. BRITISH JOURNAL OF PHARMACOLOGY
- Role of the endocannabinoid system in drug addiction
- (2018) Jorge Manzanares et al. BIOCHEMICAL PHARMACOLOGY
- Cannabidiol skews biased agonism at cannabinoid CB1 and CB2 receptors with smaller effect in CB1-CB2 heteroreceptor complexes
- (2018) Gemma Navarro et al. BIOCHEMICAL PHARMACOLOGY
- Cannabidiol treatment reduces the motivation to self-administer methamphetamine and methamphetamine-primed relapse in rats
- (2018) Gracie L Hay et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Repeated Cannabidiol treatment reduces cocaine intake and modulates neural proliferation and CB1R expression in the mouse hippocampus
- (2018) Miguel Ángel Luján et al. NEUROPHARMACOLOGY
- Report of Objective Clinical Responses of Cancer Patients to Pharmaceutical-grade Synthetic Cannabidiol
- (2018) JULIAN KENYON et al. ANTICANCER RESEARCH
- Long-Term Safety, Tolerability, and Efficacy of Cannabidiol in Children with Refractory Epilepsy: Results from an Expanded Access Program in the US
- (2018) Tristan T. Sands et al. CNS DRUGS
- Behavioral effects of psychostimulants in mutant mice with cell-type specific deletion of CB2 cannabinoid receptors in dopamine neurons
- (2018) Ana Canseco-Alba et al. BEHAVIOURAL BRAIN RESEARCH
- Endocannabinoid modulation of homeostatic and non-homeostatic feeding circuits
- (2017) Benjamin K. Lau et al. NEUROPHARMACOLOGY
- Neuronal and molecular effects of cannabidiol on the mesolimbic dopamine system: Implications for novel schizophrenia treatments
- (2017) Justine Renard et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- KK-92A, a novel GABAB receptor positive allosteric modulator, attenuates nicotine self-administration and cue-induced nicotine seeking in rats
- (2017) Xia Li et al. PSYCHOPHARMACOLOGY
- Phytocannabinoids modulate emotional memory processing through interactions with the ventral hippocampus and mesolimbic dopamine system: implications for neuropsychiatric pathology
- (2017) Roger Hudson et al. PSYCHOPHARMACOLOGY
- Expression of functional cannabinoid CB2receptor in VTA dopamine neurons in rats
- (2016) Hai-Ying Zhang et al. ADDICTION BIOLOGY
- Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a Novel mTOR/p70S6 Kinase Signaling Pathway
- (2016) Justine Renard et al. JOURNAL OF NEUROSCIENCE
- Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
- (2016) Orrin Devinsky et al. LANCET NEUROLOGY
- Antipsychotic-like Effects of M 4 Positive Allosteric Modulators Are Mediated by CB 2 Receptor-Dependent Inhibition of Dopamine Release
- (2016) Daniel J. Foster et al. NEURON
- Stress and Sucrose Intake Modulate Neuronal Activity in the Anterior Hypothalamic Area in Rats
- (2016) Arojit Mitra et al. PLoS One
- Genetic Versus Pharmacological Assessment of the Role of Cannabinoid Type 2 Receptors in Alcohol Reward-Related Behaviors
- (2015) Matthew S. Powers et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
- (2015) R B Laprairie et al. BRITISH JOURNAL OF PHARMACOLOGY
- Molecular Targets of Cannabidiol in Neurological Disorders
- (2015) Clementino Ibeas Bih et al. Neurotherapeutics
- Aiming for allosterism: Evaluation of allosteric modulators of CB1 in a neuronal model
- (2015) Alex Straiker et al. PHARMACOLOGICAL RESEARCH
- Cannabis sativaand the Endogenous Cannabinoid System: Therapeutic Potential for Appetite Regulation
- (2015) Jonathan A. Farrimond et al. PHYTOTHERAPY RESEARCH
- Species Differences in Cannabinoid Receptor 2 and Receptor Responses to Cocaine Self-Administration in Mice and Rats
- (2014) Hai-Ying Zhang et al. NEUROPSYCHOPHARMACOLOGY
- The endocannabinoid system and appetite: relevance for food reward
- (2014) Gerry Jager et al. NUTRITION RESEARCH REVIEWS
- Cannabinoid CB2receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice
- (2014) Hai-Ying Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of cannabinoid CB2receptor in the reinforcing actions of ethanol
- (2013) Antonio Ortega-Álvaro et al. ADDICTION BIOLOGY
- Cannabidiol reduces cigarette consumption in tobacco smokers: Preliminary findings
- (2013) Celia J.A. Morgan et al. ADDICTIVE BEHAVIORS
- Long-term CB1 receptor blockade enhances vulnerability to anxiogenic-like effects of cannabinoids
- (2013) Simone Tambaro et al. NEUROPHARMACOLOGY
- Cannabidiol inhibits the reward-facilitating effect of morphine: involvement of 5-HT1Areceptors in the dorsal raphe nucleus
- (2012) Vicky Katsidoni et al. ADDICTION BIOLOGY
- Potential Protective Effects of Cannabidiol on Neuroanatomical Alterations in Cannabis Users and Psychosis: A Critical Review
- (2012) Derik Hermann et al. CURRENT PHARMACEUTICAL DESIGN
- Acute Effects of a Single, Oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) Administration in Healthy Volunteers
- (2012) R. Martin-Santos et al. CURRENT PHARMACEUTICAL DESIGN
- AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: Implications for opioid/cannabinoid interaction studies
- (2012) Kathryn A. Seely et al. NEUROPHARMACOLOGY
- Decreased Cocaine Motor Sensitization and Self-Administration in Mice Overexpressing Cannabinoid CB2 Receptors
- (2012) Auxiliadora Aracil-Fernández et al. NEUROPSYCHOPHARMACOLOGY
- Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
- (2012) A. C. Campos et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Cannabinol and cannabidiol exert opposing effects on rat feeding patterns
- (2012) Jonathan A. Farrimond et al. PSYCHOPHARMACOLOGY
- Cannabinoids inhibit the synaptic uptake of adenosine and dopamine in the rat and mouse striatum
- (2011) Pablo Pandolfo et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Brain cannabinoid CB2 receptors modulate cocaine's actions in mice
- (2011) Zheng-Xiong Xi et al. NATURE NEUROSCIENCE
- Sucrose modifies c-fos mRNA expression in the brain of rats maintained on feeding schedules
- (2011) A. Mitra et al. NEUROSCIENCE
- Cannabidiol inhibits the hyperphagia induced by cannabinoid-1 or serotonin-1A receptor agonists
- (2011) América A. Scopinho et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Cannabis with high cannabidiol content is associated with fewer psychotic experiences
- (2011) Christian D. Schubart et al. SCHIZOPHRENIA RESEARCH
- Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
- (2010) José Alexandre S Crippa et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabidiol decreases body weight gain in rats: Involvement of CB2 receptors
- (2010) Bogna Ignatowska-Jankowska et al. NEUROSCIENCE LETTERS
- Cannabidiol, a Nonpsychotropic Component of Cannabis, Inhibits Cue-Induced Heroin Seeking and Normalizes Discrete Mesolimbic Neuronal Disturbances
- (2009) Y. Ren et al. JOURNAL OF NEUROSCIENCE
- The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic–ischemic brain damage in mice is mediated by CB2 and adenosine receptors
- (2009) A. Castillo et al. NEUROBIOLOGY OF DISEASE
- Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis
- (2009) Vanessa Deveaux et al. PLoS One
- The future of endocannabinoid-oriented clinical research after CB1 antagonists
- (2009) Bernard Le Foll et al. PSYCHOPHARMACOLOGY
- A nonsynonymous polymorphism in cannabinoid CB2 receptor gene is associated with eating disorders in humans and food intake is modified in mice by its ligands
- (2009) H. Ishiguro et al. SYNAPSE
- Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis
- (2008) Celia J. A. Morgan et al. BRITISH JOURNAL OF PSYCHIATRY
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
- The orphan receptor GPR55 is a novel cannabinoid receptor
- (2007) E Ryberg et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
- (2007) A Thomas et al. BRITISH JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now